Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study conducted as part of the USA National Toxicology Program.

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1991

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
yes
Remarks:
Minor
Principles of method if other than guideline:
Essentially OECD 471
GLP compliance:
not specified
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Tris(2-chloroethyl) phosphate
EC Number:
204-118-5
EC Name:
Tris(2-chloroethyl) phosphate
Cas Number:
115-96-8
Molecular formula:
C6H12Cl3O4P
IUPAC Name:
tris(2-chloroethyl) phosphate
Details on test material:
Not specified

Method

Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Additional strain / cell type characteristics:
not specified
Metabolic activation:
with and without
Metabolic activation system:
Aroclor 1254-induced Sprague-Dawley rat or Syrian hamster liver
Test concentrations with justification for top dose:
5 concentrations, up to limit of toxicity/solubility (did not exceed 3,333 mcg/plate)
Vehicle / solvent:
Buffer or S9 mix
Details on test system and experimental conditions:
Incubation for 20 minutes at 37 degC prior to the addition of soft agar supplemented with l-histidine and d-biotin. Subsequent plating on minimal
glucose plates. Incubation continued for an additional 48 hours.
Each test consisted of triplicate plates of concurrent positive and negative controls and at least 5 concentrations of test material.
Evaluation criteria:
Positive response defined as a reproducible, dose-related increase in histidine-dependent (revertant) colonies in any one strain/activation
combination. An equivocal response defined as an increase in revertants which was not dose-related, not reproducible, or of insufficient magnitude to support a determination of mutagenicity. Negative response obtained when no increase in revertant colonies was observed following treatment.
Statistics:
Not specified

Results and discussion

Test results
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
not specified
Untreated negative controls validity:
not specified
Positive controls validity:
not specified
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Negative in the reverse mutation assay in vitro when tested in Salmonella typhimurium strains TA100, TA1535, TA1537 and TA98 in a preincubation protocol, with and without metabolic activation.